You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 13, October 4, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Law and Medicine
 •Quality of Care
 •Quality of Care, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Performance Measures and Medical Malpractice—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: We analyzed the "inculpatory" potential of PCPA data—that is, the likelihood that such data may be used against physicians in malpractice litigation. Based on an analysis of the law of evidence, we concluded that this is unlikely. Dr Luft raises the possibility of "exculpatory" uses. Could physicians deploy their own PCPA data to defend against malpractice claims? For proponents of PCPA, particularly those working to overcome physician resistance to these measures, Luft's notion is a hopeful one. However, the law is not on his side.

Physician clinical performance assessment highlights patterns of care for practitioners or groups of practitioners. Because PCPA is not directly connected to the particular issue in dispute, it constitutes "other act" evidence, akin to litigants' past behavior or known character traits. Civil courts have generally ruled this type of evidence inadmissible irrespective of which side seeks to introduce it. The rationale is that indirect . . . [Full Text of this Article]

Aaron S. Kesselheim, MD, JD
akesselheim@partners.org
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital

David M. Studdert, LLB, ScD, MPH
Department of Health Policy and Management
Harvard School of Public Health
Boston, Mass



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Clinical Performance Measures and Medical Malpractice
Harold S. Luft
JAMA. 2006;296(13):1589.
EXTRACT | FULL TEXT  

Will Physician-Level Measures of Clinical Performance Be Used in Medical Malpractice Litigation?
Aaron S. Kesselheim, Timothy G. Ferris, and David M. Studdert
JAMA. 2006;295(15):1831-1834.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.